Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from WHO

Covid Eris symptoms: All we know about new variant driving surge in cases

Eris desends from Omicron and is now the second most prevalent Covid variant in the UK

The Independent UK

In TB detection, smear microscopy’s share still holds sway

India's TB diagnosis rate is low, with over 40% of 10.6 million people globally who developed TB in 2021 not diagnosed. India, Indonesia, and Philippines account for 67% drop in diagnosis in 2020 due to COVID-19. India has been overly relying on smear microscopy for initial diagnosis, despite WHO guidelines…

The Hindu

Covid Eris symptoms: All we know about new variant driving surge in cases

Eris desends from Omicron and is now the second most prevalent Covid variant in the UK

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Intensified Mission Indradhanush 5.0 from Monday

Intensified Mission Indradhanush (IMI) 5.0, the vaccine catch-up campaign, which focusses on reaching zero-dose children aged between 0 and 5 years and pregnant women who might have missed any vaccine doses in the national immunisation schedule, will begin on August 7

The Hindu

Mo Foster obituary

Other Lives: Session bass guitarist who played on many hit singles and albums

The Guardian - UK

India needs evidence-based, ethics-driven medicine

Systematic reviews and meta-analyses have found that across ailments, population groups, study types, and treatment regimes, homoeopathic treatments lack clinically significant effects

The Hindu

The many challenges of ensuring maternal and child health in India

A WHO, UNICEF, UNFPA paper titled ‘Improving maternal and newborn health and survival and reducing stillbirth progress report 2023’, observed that India’s share of the total maternal and newborn deaths and stillbirths was about 17%. Both newborns and women are extremely vulnerable in the hours and days after birth and therefore…

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Health Ministry sets deadline for pharma industry to implement revised Schedule M

GMP comprises mandatory standards that build and bring quality to products by way of control on materials, methods, machines, processes, personnel, and facility or environment, etc. The GMP system was first incorporated in 1988 in Schedule M of the Drugs and Cosmetics Rules, 1945, and the last amendment was done…

The Hindu

‘Black suffering’: Henrietta Lacks medical research lawsuit settled in US

Cells taken in 1951 from Lacks, a Black woman, without her knowledge became the cornerstone of modern medical research.

Al Jazeera

As climate change leads to more and wetter storms, cholera cases are on the rise

As the planet warms thanks to climate change, tropical storms are becoming more frequent, more powerful, and wetter

The Independent UK

Single-pill strategy to beat cardiovascular diseases gets WHO recognition

WHO adds polypills to EML 2023, a major policy change. Clinical evidence shows polypills reduce risk of cardiovascular events, incl. heart attack & stroke. Salim Yusuf, a Keralite, spent two decades building evidence for polypill's safety & efficacy. Polypill reduces risk by 40-50%. Govts. should purchase & provide polypill at…

The Hindu

You Can Just Work Out On Weekends — And Still Get Results

Can you only work out on the weekends? New research shows shows that on most health metrics, it’s about cumulative time instead of regularity.

Inverse

Threat of dengue fever escalates globally

The article discusses the alarming surge in dengue cases globally, with regions like America, Europe, and the Middle East reporting significant outbreaks in 2023. Dengue, caused by the dengue virus with four serotypes, poses a significant health challenge due to global warming favoring disease-transmitting mosquitoes. Efforts to control the disease…

The Hindu

TB: over 85% cure rate seen in modified BPaL regimen trial

A randomized phase-3/4 trial conducted in India to assess a short-course treatment for pre-XDR TB or treatment intolerant/non-responsive MDR pulmonary TB has shown promising results. The trial used a combination of three drugs (bedaquiline, pretomanid, and linezolid) for a duration of 26 weeks, resulting in higher treatment adherence and an…

The Hindu

Get all your
news in one place.

100’s of premium titles.
One news app.

Zenger

Professors Highlight Ultraviolet Air Disinfection As Key Solution For Covid-19 Spread In High-Risk Environments

Big Tech Suppressed Highly Effective Technology to Prevent Spread of Covid-19, Costing Countless Lives

The Conversation

Measles: it's not just London that's at risk of an outbreak – it's all of the UK

Since the start of 2023, measles has been reported in a third of countries in the World Health Organization (WHO) European region. And in the first five months of the year, there were 5,699 cases reported there – nearly seven times as many as in the whole of 2022.

The Independent UK

Indonesian police crack down on traffickers who sent 122 people to sell their kidneys in Cambodia

Indonesian police are investigating the illegal trade in human organs involving police and immigration officers who were accused of helping traffickers send 122 Indonesians to a hospital in Cambodia to sell their kidneys

The Independent UK

Man tests positive for potentially fatal MERS-CoV virus in Abu Dhabi

Man without any contact with dromedary camels test positive for MERS-CoV

Get all your
news in one place.

100’s of premium titles.
One news app.

The Times of India

28 year old tests positive for MERS in Abu Dhabi; know what are the signs

A new case of MERS or the Middle East respiratory syndrome coronavirus has come to the fore, Reuters reported. The 28-year-old man has tested positive for MERS in a city in Abu Dhabi on the border with Oman, media has cited the World Health Organisation (WHO).

The Hindu

Explained | Will generic supply of bedaquiline be accessible?

J&J's patent on bedaquiline expired, allowing generic manufacturers to supply the drug. J&J has filed secondary patents. Prices are expected to reduce 3-6x, but some countries are excluded from the deal, raising concerns.

The Hindu

Science This Week | New way to settle the universe expansion dispute, risk of dengue on the rise as the planet warms and more

Check out The Hindu’s science wrap featuring top 7 stories on new discoveries, findings, and studies in the scientific world from this week.

The Hindu

Taking healthcare to the people | The complete Makkalai Thedi Maruthuvam experience in Tamil Nadu

Tamil Nadu's Makkalai Thedi Maruthuvam (MTM) is a path-breaking project providing surveillance and intervention for health needs of its people. It has improved accessibility, early detection of diabetes/hypertension, and reduced out-of-pocket expenditure. Challenges remain, such as human resources, data accuracy, drug delivery, and evaluating outcomes. WHVs, VHNs, and digital tools…

The Hindu

WHO warns of dengue risk as global warming pushes cases near historic highs

Dengue fever cases could reach record highs this year due to global warming, WHO warns.

The Guardian - UK

‘I lived in this tee for six years’: readers remember beloved band T-shirts

Guardian readers pick their favourite band T-shirts, including a threadbare Led Zeppelin tee, a much-loved Waterboys garment and an exhaustive the Who collection

Zenger

AI System Detects COVID-19 Variants Of Concern Before WHO Designation

Scientists develop machine-learning tool to track virus evolution and predict potential pandemics

1 … 99 100 101 102

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

883 stories

Ministry

617 stories

the World Health Organization

the World Health Organisation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.